Trial intelligence / Profile preview

INSTIN: Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction

NCT01089387Phase 2Completed

Sponsor
Inserm
Start
May 2010
Primary completion
May 2012
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of bone marrow mononuclear cells in erectile dysfunction (ED), sponsored by Inserm. Started May 2010; status: completed.

02

Drugs

bone marrow mononuclear cells
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT01089387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01089387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call